Research location
East Melbourne
Victoria, Australia
Advertisement
Research activity in East Melbourne
Victoria, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 75 trials and 78 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in East Melbourne
75 linked trials · page 1 of 2DIAG723 in Adults With Hereditary Hemorrhagic TelangiectasiaNCT07623525 · 2026-06-04 · 1 site observation
RECRUITING
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerNCT07213674 · 2025-11-28 · 1 site observation
RECRUITING
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing LumpectomyNCT05866458 · 2024-03-12 · 1 site observation
RECRUITING
Phase IIIb Study of Ribociclib + ET in Early Breast CancerNCT05827081 · 2024-02-28 · 1 site observation
RECRUITING
VividWhite Glaucoma Implant (VW-51) Pivotal StudyNCT06176170 · 2023-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesNCT05794906 · 2023-04-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle GlaucomaNCT05411198 · 2022-07-22 · 1 site observation
COMPLETED
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)NCT05094336 · 2022-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)NCT04799249 · 2021-05-14 · 1 site observation
COMPLETED
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase InhibitorNCT04650581 · 2021-01-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid TumorsNCT04672460 · 2020-12-21 · 2 site observations
COMPLETED
A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast CancerNCT04298918 · 2020-09-23 · 1 site observation
TERMINATED
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic RetinopathyNCT04265261 · 2020-06-05 · 1 site observation
COMPLETED
Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate GlaucomaNCT04060758 · 2020-03-11 · 1 site observation
COMPLETED
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionNCT03850782 · 2019-02-28 · 1 site observation
COMPLETED
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBCNCT03562637 · 2018-12-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle GlaucomaNCT03604328 · 2018-07-24 · 1 site observation
COMPLETED
A Comparison of Cataract Surgery Alone and Cataract Surgery With iStentNCT03106181 · 2018-02-01 · 1 site observation
COMPLETED
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)NCT03337698 · 2017-12-27 · 1 site observation
TERMINATED
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast CancerNCT02889874 · 2017-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based TherapyNCT02924883 · 2016-09-26 · 1 site observation
COMPLETED
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating MutationsNCT02588261 · 2016-02-11 · 1 site observation
TERMINATED
An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based ChemotherapyNCT02538666 · 2015-10-13 · 1 site observation
COMPLETED
Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast CancerNCT02506556 · 2015-09-07 · 1 site observation
COMPLETED
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionNCT02507687 · 2015-08-27 · 1 site observation
COMPLETED
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.NCT02422615 · 2015-06-09 · 1 site observation
COMPLETED
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCNCT02438007 · 2015-06-01 · 1 site observation
TERMINATED
Study of ES414 in Metastatic Castration-Resistant Prostate CancerNCT02262910 · 2015-01-01 · 1 site observation
COMPLETED
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)NCT02273973 · 2014-11-12 · 1 site observation
COMPLETED
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate CancerNCT02446405 · 2014-03-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerNCT01958021 · 2013-12-17 · 1 site observation
COMPLETED
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)NCT01945775 · 2013-10-14 · 1 site observation
COMPLETED
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsNCT01953926 · 2013-09-30 · 1 site observation
TERMINATED
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast CancerNCT01822314 · 2013-04-01 · 2 site observations
COMPLETED
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilationNCT01164592 · 2012-08-01 · 1 site observation
COMPLETED
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaNCT01578707 · 2012-06-01 · 1 site observation
COMPLETED
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular EdemaNCT01506895 · 2012-02-01 · 1 site observation
COMPLETED
Intravitreal Aflibercept Injection in Vision Impairment Due to DMENCT01331681 · 2011-05-09 · 1 site observation
COMPLETED
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The LungNCT01154140 · 2011-01-13 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerNCT01212991 · 2010-09-16 · 1 site observation
COMPLETED
A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung CancerNCT01121575 · 2010-08-01 · 1 site observation
COMPLETED
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)NCT01077154 · 2010-06-02 · 1 site observation
TERMINATED
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) GeneNCT00932451 · 2010-01-01 · 1 site observation
COMPLETED
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) GeneNCT00932893 · 2009-09-01 · 1 site observation
COMPLETED
Radiotherapy - Adjuvant Versus Early SalvageNCT00860652 · 2009-03-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast CancerNCT00553410 · 2007-08-01 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.